Novartis expected to report revenue of $14.47 billion on October 27
Analysts polled by LSEG expect Novartis to post a 4.0% revenue rise to $14.47 billion and EPS of $2.29 when it reports on October 27.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
Swiss drugmaker Novartis AG is scheduled to report results for the quarter ended September 30, 2026 on October 27. According to Earnings Preview, citing LSEG data, revenue is expected to reach about $14.47 billion, up 4.0% from $13.91 billion a year earlier. The mean earnings estimate of seven analysts stands at $2.29 per share, unchanged over the past three months.
Analyst sentiment is cautious. Four analysts rate the shares buy, six hold and two sell. The median 12-month price target is $156.00, roughly in line with the last close of $156.27.
why it matters
Novartis is one of the largest pharmaceutical companies, so its results can shift sentiment across healthcare and the Swiss market. In the previous quarter, according to the same source, the company beat its profit forecast, while the March 2026 quarter came in slightly below estimates.
market impact
Фарма и Швейцария: отчет 27 октября задаст ориентиры для сектора здравоохранения
tags
instruments
sources
- Novartis AG expected to post earnings of $2.29 a share — Earnings Preview, 23 October 2026 at 07:31 UTC
- Novartis AG expected to post earnings of $2.27 a share — Earnings Preview, 23 October 2026 at 07:32 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗